Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675701 · ClinicalTrials.gov registry record · Phase 1
A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study
A Phase 1 study, sponsored by CardioKine.
- Completed
- Registry status
- Phase 1
- Development phase
- 298
- Enrollment target
NCT00675701: Completed Phase 1 study, sponsored by CardioKine.
NCT00675701 is a Phase 1 study that has completed, run by CardioKine. The registered enrollment target is 298 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (397% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675701, a Phase 1 study, has completed, sponsored by CardioKine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 298 participants
- Enrollment target
Study Summary
This is a Phase 1, double-blind, randomized, repeat-dose, single -dite, 4-arm parallel group study to define the ECG effect of lixivaptan using a therapeutic and supratherapeutic dose compared to placebo and moxifloxacin (a positive control in healthy adult men and women.
Interventions
- DRUG placebo
- DRUG moxifloxacin
- DRUG lixivaptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
What the finished NCT00675701 record still lists
NCT00675701 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (397% higher).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00675701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00675701 about?
NCT00675701 is a clinical study titled "A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study". This is a Phase 1, double-blind, randomized, repeat-dose, single -dite, 4-arm parallel group study to define the ECG effect of lixivaptan using a therapeutic and supratherapeutic dose compared to placebo and moxifloxacin (a positive control in healthy adult men and women.
What is the current status of trial NCT00675701?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 298 participants. The study started on 2008-05. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00675701?
The interventions under investigation include: placebo (DRUG), moxifloxacin (DRUG), lixivaptan (DRUG).
Who is sponsoring clinical trial NCT00675701?
This trial is sponsored by CardioKine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00675701's enrollment target sits among peer trials
298 134th of 2000 higher than 1,866 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia